Comparison of Leukapheresis Products from Patients with AML and ALL Suggests Increased T-cell Exhaustion Among Patients with AML

Key Points

• T-cell exhaustion appears more pronounced in leukapheresis products of AML patients, indicating a potential biomarker.
• Comparative analysis shows an increase in inhibitory receptors on T-cells in AML compared to ALL.
• Assessment examined leukapheresis products from patients diagnosed with AML and ALL to uncover differences.
• Findings highlight the need to address T-cell exhaustion in AML treatment strategies for better outcomes.